about
MR-based molecular imaging of the brain: the next frontier.Comparing proton density and turbo spin echo T2 weighted static sequences with dynamic half-Fourier single-shot TSE pulse sequence at 3.0 T in diagnosis of temporomandibular joint disorders: a prospective study.Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.Synthesis, complexation and NMR relaxation properties of Gd3+ complexes of Mes(DO3A)3.Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.Design of targeted cardiovascular molecular imaging probes.k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T.Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.Optical and opto-acoustic interventional imaging.MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3T.MR imaging of renal collecting system with gadoxetate disodium: feasibility for MR urography.Contrast Extravasation versus Hemorrhage after Thrombectomy in Patients with Acute Stroke.3D MRI in multiple sclerosis: a study of three sequences at 3 T.High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.[Researcher of the month].
P2860
Q33701395-DC6579BB-1540-4023-BA7F-7E860B8B3DE1Q33782416-69724B40-5112-4A52-B0F0-2AE8477099E9Q33852473-E9048AC7-E125-4561-AF8F-FB94F1443254Q33858379-68A4C411-2111-422E-9BC3-32C43911B70AQ34189855-419EE409-4E59-4599-B17C-A5A83D1384D2Q36777401-7D93C572-7062-4B6F-A93A-934F65D97C5FQ36982363-4AB1385E-63EF-4E94-BC22-67885C3A7CC2Q37314667-E4169CF5-470C-41B2-B5D4-F270CF263985Q37974089-8C850BCB-DDE3-4E84-809E-6AAFADC82A0FQ46107796-378E156B-94BE-4D33-9604-1B27332E7844Q46525950-74FA2478-B472-4171-B0DF-158DCF1A5389Q47114245-1044DDF6-3AFD-4B95-8C10-85C155A1D0D7Q48411604-04451AF4-FD08-4C2F-8700-8455D18127F2Q51907943-8B82B23E-6358-42D8-A607-23350D2211D3Q52337309-55472F37-93E6-4479-B7C9-811427F22241
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The optimal use of contrast agents at high field MRI.
@ast
The optimal use of contrast agents at high field MRI.
@en
type
label
The optimal use of contrast agents at high field MRI.
@ast
The optimal use of contrast agents at high field MRI.
@en
prefLabel
The optimal use of contrast agents at high field MRI.
@ast
The optimal use of contrast agents at high field MRI.
@en
P2093
P2860
P1433
P1476
The optimal use of contrast agents at high field MRI.
@en
P2093
Ahmed Ba-Ssalamah
Iris-Melanie Nöbauer-Huhmann
Kathia Pinker
Siegfried Trattnig
P2860
P2888
P304
P356
10.1007/S00330-006-0154-0
P407
P577
2006-03-01T00:00:00Z
P6179
1015812070